DETERMINATION OF DEFENSIN HNP-1 IN HUMAN SALIVA OF PATIENTS WITH ORAL MUCOSAL DISEASES
dc.contributor.author | Kucukkolbasi, Hasan | |
dc.contributor.author | Kucukkolbasi, Semahat | |
dc.contributor.author | Dursun, Recep | |
dc.contributor.author | Ayyildiz, Filiz | |
dc.contributor.author | Kara, Huseyin | |
dc.date.accessioned | 2020-03-26T18:14:06Z | |
dc.date.available | 2020-03-26T18:14:06Z | |
dc.date.issued | 2011 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | Saliva is a biological fluid that is easily obtainable and that can give useful information both in systemic and oral diseases. In this study, a chromatographic method was applied to determine the amount of defensin HNP-1 in human saliva of patients with oral mucosal diseases before and after treatments and compared with controls. Defensin human neutrophil peptide-1 (HNP-1) was identified and confirmed. The concentration of HNP-1 in saliva was determined by comparing the area of eluted HNP-1 with that of HNP-1 standard. Linear calibration range of defensin HNP-1 was 0.10 to 0.90 mu g/10 mu L with R(2) values of 0.996. The concentrations of HNP-1 in the saliva of patients with oral lichen planus, Behcet's disease, and recurrent apthous stomatitis were 33.6 +/- 10.6, 15.5 +/- 7.6, and 36.3 +/- 9.5 mu gmL(-1) (mean +/- S.D.), respectively. The salivary defensin-1 concentration was significantly higher in patients with oral mucosal diseases than in healthy volunteers; furthermore, in patients with oral mucosal diseases, the concentration was significantly higher before treatment than after treatment. | en_US |
dc.identifier.doi | 10.1080/15321819.2011.569045 | en_US |
dc.identifier.endpage | 295 | en_US |
dc.identifier.issn | 1532-1819 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 21728821 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 284 | en_US |
dc.identifier.uri | https://dx.doi.org/10.1080/15321819.2011.569045 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/26306 | |
dc.identifier.volume | 32 | en_US |
dc.identifier.wos | WOS:000293068700003 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | TAYLOR & FRANCIS INC | en_US |
dc.relation.ispartof | JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | defensin | en_US |
dc.subject | HNP-1 | en_US |
dc.subject | HPLC | en_US |
dc.subject | oral disease | en_US |
dc.subject | saliva | en_US |
dc.title | DETERMINATION OF DEFENSIN HNP-1 IN HUMAN SALIVA OF PATIENTS WITH ORAL MUCOSAL DISEASES | en_US |
dc.type | Article | en_US |